Paliperidon Teva (Paliperidone)

Paliperidone, the active ingredient in Paliperidon Teva, is a atypical antipsychotic presented as an intramuscular injection for psychiatric use. It is primarily indicated for the treatment of schizophrenia and related psychotic disorders in adults. GNH USA supplies Paliperidon Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Paliperidon Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Paliperidon Teva is used in the management of psychotic disorders, targeting dopamine pathways that contribute to symptom control.

- Schizophrenia: Reduces positive and negative symptoms and helps maintain stability. - Schizoaffective disorder: Controls mood swings and psychotic features. - Bipolar I disorder (acute manic episodes): Assists in controlling manic symptoms when used as part of a broader treatment plan.

Adverse reactions to Paliperidon Teva may vary in frequency and severity.

Common Side Effects: - Ak Ak   -     t -     -  - -

Serious or Rare Side Effects: -  -  -  -  t -  t - 

Paliperidon  

-   t   t  ewline   ewline  

-  ewline  ewline  ewline  ewline  ewline  ewline.

-